Thiophene donor for NIR-II fluorescence imaging-guided photothermal/photodynamic/chemo combination therapy
- PMID: 33831570
- DOI: 10.1016/j.actbio.2021.03.064
Thiophene donor for NIR-II fluorescence imaging-guided photothermal/photodynamic/chemo combination therapy
Erratum in
-
Corrigendum to 'Thiophene donor for NIR-II fluorescence imaging guided photothermal/photodynamic/chemo combination therapy' [Acta Biomaterialia 127 (2021) 287-297].Acta Biomater. 2022 Apr 1;142:432. doi: 10.1016/j.actbio.2022.01.026. Epub 2022 Jan 19. Acta Biomater. 2022. PMID: 35063373 No abstract available.
Abstract
Organic fluorophores/photosensitizers have been widely used in biological imaging and photodynamic and photothermal combination therapy in the first near-infrared (NIR-I) window. However, their applications in the second near-infrared (NIR-II) window are still limited primarily due to low fluorescence quantum yields (QYs). Here, a boron dipyrromethene (BDP) is created as a molecularly engineered thiophene donor unit with high QYs to the redshift. Thiophene insertion initiates substantial redshifts of the absorbance as compared to its counterparts in which iodine is introduced. The fluorescent molecule can be triggered by an NIR laser with a single wavelength, thereby producing emission in the NIR-II windows. Single NIR laser-triggered phototherapeutic nanoparticles (NPs) are developed by encapsulating the BDP and the chemotherapeutic drug docetaxel (DTX) by using a synthetic amphiphilic poly(styrene-co-chloromethyl styrene)-graft-poly(ethylene glycol) functionalized with folic acid (FA). These BDP-T-N-DTX-FA NPs not only show superior solubility and high singlet oxygen QY (ΦΔ=62%) but also demonstrate single NIR laser-triggered multifunctional characteristics. After intravenous administration of the NPs into 4T1 tumor-bearing mice, the accumulation of the NPs in the tumor showed a high signal-to-background ratio (11.8). Furthermore, 4T1 tumors in mice were almost eradicated by DTX released from the BDP-T-N-DTX-FA NPs under single NIR laser excitation and the combination of photodynamic therapy (PDT) and photothermic therapy (PTT). STATEMENT OF SIGNIFICANCE: The application of organic photosensitizers is still limited primarily due to low fluorescence quantum yields (QYs) in the second near-infrared (NIR-II) window. Here, a boron dipyrromethene (BDP) as a molecularly engineered thiophene donor unit with high QYs to the redshift is created. Phototherapeutic nanoparticles (NPs) are developed by encapsulating the BDP and docetaxel (DTX) using a synthetic amphiphilic poly(styrene-co-chloromethyl styrene)-graft-poly(ethylene glycol) functionalized with folic acid (FA). These BDP-T-N-DTX-FA NPs not only show high singlet oxygen QY (ΦΔ=62%) but also demonstrate single NIR laser-triggered multifunctional characteristics and a high signal-to-background ratio (11.8). Furthermore, 4T1 tumors in mice were almost eradicated by DTX released from the BDP-T-N-DTX-FA NPs under single NIR laser excitation and the PDT/PTT combination therapy.
Keywords: Molecular imaging; NIR-II fluorophore probe; Photothermal/photodynamic/chemo combination therapy; Single laser triggering; Thiophene donor.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Thiophene engineering of near-infrared D-π-A nano-photosensitizers for enhanced multiple phototheranostics and inhibition of tumor metastasis.J Colloid Interface Sci. 2025 May;685:291-303. doi: 10.1016/j.jcis.2025.01.118. Epub 2025 Jan 17. J Colloid Interface Sci. 2025. PMID: 39848063
-
Near-Infrared-II Nanoparticles for Cancer Imaging of Immune Checkpoint Programmed Death-Ligand 1 and Photodynamic/Immune Therapy.ACS Nano. 2021 Jan 26;15(1):515-525. doi: 10.1021/acsnano.0c05317. Epub 2021 Jan 11. ACS Nano. 2021. PMID: 33426893
-
Novel BODIPY-based nano-biomaterials with enhanced D-A-D structure for NIR-triggered photodynamic and photothermal therapy.Bioorg Chem. 2024 Jul;148:107494. doi: 10.1016/j.bioorg.2024.107494. Epub 2024 May 23. Bioorg Chem. 2024. PMID: 38797067
-
BODIPY-Based Multifunctional Nanoparticles for Dual Mode Imaging-Guided Tumor Photothermal and Photodynamic Therapy.ACS Appl Bio Mater. 2023 Sep 18;6(9):3406-3413. doi: 10.1021/acsabm.3c00083. Epub 2023 Mar 30. ACS Appl Bio Mater. 2023. PMID: 36996306 Review.
-
A comprehensive review on singlet oxygen generation in nanomaterials and conjugated polymers for photodynamic therapy in the treatment of cancer.Nanoscale. 2024 Feb 15;16(7):3243-3268. doi: 10.1039/d3nr05801h. Nanoscale. 2024. PMID: 38265094 Review.
Cited by
-
PpIX/IR-820 Dual-Modal Therapeutic Agents for Enhanced PDT/PTT Synergistic Therapy in Cervical Cancer.ACS Omega. 2022 Sep 15;7(49):44643-44656. doi: 10.1021/acsomega.2c02977. eCollection 2022 Dec 13. ACS Omega. 2022. PMID: 36530282 Free PMC article.
-
Thiophene Stability in Photodynamic Therapy: A Mathematical Model Approach.Int J Mol Sci. 2024 Feb 21;25(5):2528. doi: 10.3390/ijms25052528. Int J Mol Sci. 2024. PMID: 38473777 Free PMC article.
-
Photothermal therapeutic effects and biosafety of a carbon nanoparticles-Fe(ii) complex for triple-negative breast cancer.RSC Adv. 2025 Jun 10;15(25):19665-19675. doi: 10.1039/d5ra03041b. eCollection 2025 Jun 10. RSC Adv. 2025. PMID: 40503306 Free PMC article.
-
Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential.Bioact Mater. 2022 Dec 5;23:471-507. doi: 10.1016/j.bioactmat.2022.11.013. eCollection 2023 May. Bioact Mater. 2022. PMID: 36514388 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous